261 related articles for article (PubMed ID: 36690175)
1. Oral delivery of nucleic acid therapeutics: Challenges, strategies, and opportunities.
Jiang X; Wang N; Liu C; Zhuo Y; Liang L; Gan Y; Yu M
Drug Discov Today; 2023 Apr; 28(4):103507. PubMed ID: 36690175
[TBL] [Abstract][Full Text] [Related]
2. Polymeric nanoparticle drug delivery technologies for oral delivery applications.
Pridgen EM; Alexis F; Farokhzad OC
Expert Opin Drug Deliv; 2015; 12(9):1459-73. PubMed ID: 25813361
[TBL] [Abstract][Full Text] [Related]
3. Oral nucleic acid therapy using multicompartmental delivery systems.
Attarwala H; Han M; Kim J; Amiji M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Mar; 10(2):. PubMed ID: 28544521
[TBL] [Abstract][Full Text] [Related]
4. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
Ensign LM; Cone R; Hanes J
Adv Drug Deliv Rev; 2012 May; 64(6):557-70. PubMed ID: 22212900
[TBL] [Abstract][Full Text] [Related]
5. Oral Delivery of Nucleic Acid Therapies for Local and Systemic Action.
Kumari N; Siddhanta K; Panja S; Joshi V; Jogdeo C; Kapoor E; Khan R; Kollala SS; Kumar B; Sil D; Singh AB; Murry DJ; Oupický D
Pharm Res; 2023 Jan; 40(1):107-122. PubMed ID: 36271204
[TBL] [Abstract][Full Text] [Related]
6. Redox-Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges.
Xu L; Cao Y; Xu Y; Li R; Xu X
Macromol Biosci; 2024 Mar; 24(3):e2300238. PubMed ID: 37573033
[TBL] [Abstract][Full Text] [Related]
7. Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems.
Subramanian DA; Langer R; Traverso G
J Nanobiotechnology; 2022 Aug; 20(1):362. PubMed ID: 35933341
[TBL] [Abstract][Full Text] [Related]
8. Engineering strategies to enhance nanoparticle-mediated oral delivery.
Yamanaka YJ; Leong KW
J Biomater Sci Polym Ed; 2008; 19(12):1549-70. PubMed ID: 19017470
[TBL] [Abstract][Full Text] [Related]
9. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.
Dilnawaz F
Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879
[TBL] [Abstract][Full Text] [Related]
10. Advanced research on extracellular vesicles based oral drug delivery systems.
Song M; Cui M; Fang Z; Liu K
J Control Release; 2022 Nov; 351():560-572. PubMed ID: 36179765
[TBL] [Abstract][Full Text] [Related]
11. Oral delivery of non-viral nucleic acid-based therapeutics - do we have the guts for this?
O'Driscoll CM; Bernkop-Schnürch A; Friedl JD; Préat V; Jannin V
Eur J Pharm Sci; 2019 May; 133():190-204. PubMed ID: 30946964
[TBL] [Abstract][Full Text] [Related]
12. Biocoating-A Critical Step Governing the Oral Delivery of Polymeric Nanoparticles.
Azagury A; Baptista C; Milovanovic K; Shin H; Morello P; Perez-Rogers J; Goldenshtein V; Nguyen T; Markel A; Rege S; Hojsak S; Perl A; Jones C; Fife M; Furtado S; Mathiowitz E
Small; 2022 Jul; 18(26):e2107559. PubMed ID: 35606684
[TBL] [Abstract][Full Text] [Related]
13. Improving oral drug bioavailability with polycations?
Schulz JD; Gauthier MA; Leroux JC
Eur J Pharm Biopharm; 2015 Nov; 97(Pt B):427-37. PubMed ID: 26614561
[TBL] [Abstract][Full Text] [Related]
14. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
[TBL] [Abstract][Full Text] [Related]
15. An overview on recent patents and technologies on nanoparticles for nucleic acid delivery.
Dos Santos Fonseca LM; Machado BAS; Oliveira FO; de Jesus Santos JR; da Silva JW; Hodel KVS; Rosatti BG; Pinto CD; Soares MBP
Expert Opin Ther Pat; 2024 Mar; 34(3):171-186. PubMed ID: 38578253
[TBL] [Abstract][Full Text] [Related]
16. Oral delivery of biomacromolecules by overcoming biological barriers in the gastrointestinal tract: an update.
Liu S; Wen X; Zhang X; Mao S
Expert Opin Drug Deliv; 2023; 20(10):1333-1347. PubMed ID: 37439101
[TBL] [Abstract][Full Text] [Related]
17. Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy.
Zhang C; Ma Y; Zhang J; Kuo JC; Zhang Z; Xie H; Zhu J; Liu T
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335310
[TBL] [Abstract][Full Text] [Related]
18. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
Xu L; Anchordoquy T
J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
[TBL] [Abstract][Full Text] [Related]
19. Smart polymeric nanocarriers for small nucleic acid delivery.
Miyata K
Drug Discov Ther; 2016 Nov; 10(5):236-247. PubMed ID: 27746418
[TBL] [Abstract][Full Text] [Related]
20. Physiological Barriers and Strategies of Lipid-Based Nanoparticles for Nucleic Acid Drug Delivery.
Hu M; Li X; You Z; Cai R; Chen C
Adv Mater; 2024 May; 36(22):e2303266. PubMed ID: 37792475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
